Cargando…
Identification of a 5-gene-based signature to predict prognosis and correlate immunomodulators for rectal cancer
BACKGROUND: Specific tumor markers have yet to be identified in rectal cancer. This study aims to identify a novel genetic signature in rectal cancer to provide clues for survival and immunotherapy. METHODS: DEGs were obtained from two GEO datasets of rectal cancer. By using data from TCGA and GSE13...
Autores principales: | Yi, Lin, Qiang, Ji, Yichen, Peng, Chunna, Yu, Yi, Zheng, Xun, Kang, Jianwei, Zheng, Rixing, Bai, Wenmao, Yan, Xiaomin, Wang, Parker, Li, Wenbin, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9493070/ https://www.ncbi.nlm.nih.gov/pubmed/36130456 http://dx.doi.org/10.1016/j.tranon.2022.101529 |
Ejemplares similares
-
PHF6 promotes the progression of endometrial carcinoma by increasing cancer cells growth and decreasing T‐cell infiltration
por: Wang, Xiaomin, et al.
Publicado: (2023) -
Identification of potential therapeutic targets for colorectal cancer by bioinformatics analysis
por: Yan, Ming, et al.
Publicado: (2016) -
Itaconate: A Potent Macrophage Immunomodulator
por: Li, Zeyu, et al.
Publicado: (2023) -
GSK3 inhibitor ameliorates steatosis through the modulation of mitochondrial dysfunction in hepatocytes of obese patients
por: Li, Yaqiong, et al.
Publicado: (2021) -
Identification of mRNA Signature for Predicting Prognosis Risk of Rectal Adenocarcinoma
por: Jiang, Linlin, et al.
Publicado: (2022)